Vakaramoko Diaby

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Systematic Review

Prognostic Factors

Ejection Fraction

Amyotrophic Lateral Sclerosis

Top Venues

Expert review of pharmacoeconomics & outcomes research

JCO oncology practice

Clinical drug investigation

BMC public health

This page only lists publications with an associated author ORCID identifier.

Publications

Mahek Garg, Veena Venugopalan, Scott Martin Vouri, Vakaramoko Diaby, Nicole M Iovine, Debbie L Wilson, Haesuk Park
Trends in the appropriateness of oral antibiotic prescriptions dispensed in the United States from 2010 to 2018. Pharmacotherapy (2024)
Askal Ayalew Ali, Rima H Tawk, Hong Xiao, Anastasia Semykina, Alberto J Montero, Richard K Moussa, Olayiwola Popoola, Vakaramoko Diaby
Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer. Expert review of pharmacoeconomics & outcomes research 22 (5) (2022)
Phuong T Tran, Munaza Riaz, Ziyan Chen, Cong Bang Truong, Vakaramoko Diaby
An Umbrella Review of the Cost Effectiveness of Human Papillomavirus Vaccines. Clinical drug investigation 42 (5) (2022)
Ziyan Chen, Aram Babcock, Vassiki Sanogo, David R Nelson, Hong Xiao, Vakaramoko Diaby
Predictors of 30-day readmission and hospitalization costs of patients with hepatic encephalopathy in the US from 2010 to 2014. Expert review of pharmacoeconomics & outcomes research (2021)
Aram Babcock, Richard K Moussa, Vakaramoko Diaby
Effects, trends, costs associated with readmission in early-aged patients with suicidal ideation. Expert review of pharmacoeconomics & outcomes research (2021)
Sascha van Boemmel-Wegmann, Joshua D Brown, Vakaramoko Diaby, Jinhai Huo, Natalie Silver, Haesuk Park
Health Care Utilization and Costs Associated With Systemic First-Line Metastatic Melanoma Therapies in the United States. JCO oncology practice (2021)
Ziyan Chen, Yue Cheng, David DeRemer, Vakaramoko Diaby
Cost-effectiveness and drug wastage of immunotherapeutic agents for hematologic malignancies: a systematic review. Expert review of pharmacoeconomics & outcomes research 21 (5) (2021)
Richard K Moussa, Vakaramoko Diaby
Self-assessed life expectancy among older adults in Côte d'Ivoire. BMC public health 20 (1) (2020)
Vakaramoko Diaby, Reem D Almutairi, Ziyan Chen, Richard K Moussa, Abdrahmane Berthe
A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19. Expert review of pharmacoeconomics & outcomes research 21 (1) (2020)
Delaney D Ding, Rajesh Balkrishnan, Vakaramoko Diaby
In our war against the opioid epidemic, could 'weed' be a winner? Expert review of pharmacoeconomics & outcomes research 20 (5) (2020)
Vakaramoko Diaby, Reem D Almutairi, Aram Babcock, Richard K Moussa, Askal Ayalew Ali
Cost-effectiveness of treatments for HER2-positive metastatic breast cancer and associated metastases: an overview of systematic reviews. Expert review of pharmacoeconomics & outcomes research 21 (3) (2020)
Arinze Nkemdirim Okere, Vassiki Sanogo, Hussain Alqhtani, Vakaramoko Diaby
Identification of risk factors of 30-day readmission and 180-day in-hospital mortality, and its corresponding relative importance in patients with Ischemic heart disease: a machine learning approach. Expert review of pharmacoeconomics & outcomes research 21 (5) (2020)
Jinhai Huo, Young-Rock Hong, Kea Turner, Vakaramoko Diaby, Cheng Chen, Jiang Bian, Reetu Grewal, Diana J Wilkie
Timing, Costs, and Survival Outcome of Specialty Palliative Care in Medicare Beneficiaries With Metastatic Non-Small-Cell Lung Cancer. JCO oncology practice 16 (12) (2020)
Vakaramoko Diaby, Askal Ayalew Ali, Krystal J Williams, Kyrian Ezendu, Enrique Soto-Perez-de-Celis, Yanin Chavarri-Guerra, Gilberto de Lima Lopes
Economic evaluation of sequencing strategies in HER2-positive metastatic breast cancer in Mexico: a contrast between public and private payer perspectives. Breast cancer research and treatment 166 (3) (2017)